Most clinical research trials investigating new
methods of cancer diagnosis or treatment are conducted at colleges of veterinary medicine.
Not exact matches
The Lund researchers have already started new studies in which a larger number
of women will be monitored from breast
cancer diagnosis and onwards, as well as testing ctDNA
methods in other
cancer types.
Recently, DNA shed from tumor cells has been identified as a noninvasive
method of screening biomarkers for the early
diagnosis and prognosis
of cancer.
For their latest report, CalCARES researchers reviewed statewide data from 1999 through 2013 to identify trends in the
diagnosis of advanced
cancers of the breast, colon and rectum, cervix, prostate, skin, and oral cavity and pharynx — six sites
of cancer for which effective screening
methods exist.
«Our ultimate goal is to develop an endoscopic photoacoustic imaging probe scanning the cervical canal, which would be a quicker, cheaper and non-invasive
method for the
diagnosis of cervical
cancer,» Xiao said.
«
Method for
diagnosis, prognosis
of melanoma — most aggressive skin
cancer — is patented.»
UPV / EHU researchers have developed a
method for the
diagnosis and prognosis
of cutaneous melanoma, the type
of skin
cancer with the highest mortality rate.This
method will help not only in the more effective early detection
of this
cancer, but also in the development
of more personalized treatments.
Researchers at The University
of Texas MD Anderson
Cancer Center have announced a new method for detecting DNA mutations in a single cancer cell versus current technology that analyzes millions of cells which they believe could have important applications for cancer diagnosis and trea
Cancer Center have announced a new
method for detecting DNA mutations in a single
cancer cell versus current technology that analyzes millions of cells which they believe could have important applications for cancer diagnosis and trea
cancer cell versus current technology that analyzes millions
of cells which they believe could have important applications for
cancer diagnosis and trea
cancer diagnosis and treatment.
DNA shed from tumour cells has been identified as a non-invasive
method of screening biomarkers for the early
diagnosis and prognosis
of cancer
A new
method offering more successful
diagnosis and management
of prostate
cancer has been identified by researchers at the University
of Dundee.
Recently, DNA shed from tumour cells has been identified as a non-invasive
method of screening biomarkers for the early
diagnosis and prognosis
of cancer.
To cite a few instances, polymerase chain reaction (PCR), a molecular
method developed over three decades ago, has been widely applied in disease
diagnosis, disease mechanism deciphering, and prognosis prediction; the elucidation
of tyrosine kinase activity in
cancer cells has led to the development
of novel drugs for
cancer treatment; and the identification
of proteins and genetic molecules by molecular
methods as biomarkers for disease
diagnosis and prognosis has been drawing great interest.
«With our
method, we utilise tissue which is used routinely for
diagnosis of breast
cancer patients.
Although the level
of tumour DNA present in the blood is much lower during the early stages
of these
cancers, the program was still able to make a
diagnosis demonstrating the potential
of this
method for the early detection
of cancer, according to the researchers.
Using translational research
methods, the DZL seeks to jointly develop new approaches for the prevention,
diagnosis and therapy
of serious lung diseases including asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, diffuse parenchymal lung disease (DPLD), endstage lung disease, lung
cancer, pneumonia and acute lung injury, and pulmonary hypertension.
Their
method, described in BMC Medical Genomics (http://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-016-0178-5), was first applied to 102 individuals at risk or with a
diagnosis of inherited breast
cancer.
This AACR Special Conference will cover the state
of the art in understanding the disease
of cancer from incident to early
diagnosis, prevention, and treatment, with an emphasis on approaches that use big data and new computational
methods such as machine learning.
Since
cancer can cause a variety
of symptoms that mimic other diseases, biopsy remains the chief
method of definitive
diagnosis.
Following a
diagnosis of canine prostate
cancer, you and your vet should discuss all possible treatment
methods.
While the base guidelines are still pretty much the same, that being that the
diagnosis level psa is 10 or below, and the
cancer is a medium to low grade and stage, there have been some shifts in acceptability
of treatment
methods and post treatment results.